GSK · CUSIP 37733W204
GSK PLC
Reported by 6 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 6
- Average portfolio weight
- 1.1%
- Combined reported value
- $2.5B
- Research group
- 79
6 of the 79 superinvestors Shameless Cloning tracks reported GSK PLC (GSK) in their Q2 2026 13F filings, worth $2.5B combined, at an average 1.1% of their portfolios. The largest positions by portfolio weight belong to Hillman Capital Management (3.5%), Dodge & Cox Funds (1.3%), Kahn Brothers Group (1.3%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Hillman Capital ManagementHillman Capital Management, Inc. | 3.5% | $4.8M |
| Dodge & Cox FundsDodge & Cox | 1.3% | $2.5B |
| Kahn Brothers GroupKAHN BROTHERS GROUP INC | 1.3% | $8.3M |
| Tweedy BrowneTweedy, Browne Co LLC | 0.3% | $4.3M |
| Richard PzenaPZENA INVESTMENT MANAGEMENT LLC | 0.0% | $1.3M |
| Sarah KettererCAUSEWAY CAPITAL MANAGEMENT LLC | 0.0% | $375K |